{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:09:07Z","timestamp":1790629747678,"version":"4.1.0"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI111159"],"award-info":[{"award-number":["R21AI111159"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R25GM106995-01"],"award-info":[{"award-number":["1R25GM106995-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["HRD-1241701"],"award-info":[{"award-number":["HRD-1241701"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["HRD-1646729"],"award-info":[{"award-number":["HRD-1646729"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02369","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:39:36Z","timestamp":1539563976000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune Responses"],"prefix":"10.3389","volume":"9","author":[{"given":"Richa","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyla A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo H.","family":"Giambartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree R.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida A.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0183101","DOI":"10.1371\/journal.pone.0183101","article-title":"A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments","volume":"12","author":"Albritton","year":"2017","journal-title":"PLoS ONE"},{"key":"B2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/imm.12317","article-title":"Evaluation of intra- and extra-epithelial secretory IgA in chlamydial infections","volume":"143","author":"Armitage","year":"2014","journal-title":"Immunology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect Immun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1586\/14760584.2016.1161510","article-title":"Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis","volume":"15","author":"Yu","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1586\/erv.11.139","article-title":"Chlamydia vaccines: recent developments and the role of adjuvants in future formulations","volume":"10","author":"Igietseme","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2147\/IJN.S44155","article-title":"Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine","volume":"8","author":"Fairley","year":"2013","journal-title":"Int J Nanomed."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.1016\/j.vaccine.2014.06.002","article-title":"Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice","volume":"32","author":"Yu","year":"2014","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1080\/21645515.2016.1252886","article-title":"Considerations for the rational design of a Chlamydia vaccine","volume":"13","author":"Liang","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"B9","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/IAI.62.8.3354-3362.1994","article-title":"Protection against infertility in a BALB\/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis","volume":"62","author":"Pal","year":"1994","journal-title":"Infect Immun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.4049\/jimmunol.179.6.4027","article-title":"Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease","volume":"179","author":"O'Connell","year":"2007","journal-title":"J Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1128\/IAI.01543-13","article-title":"Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid-free Chlamydia muridarum","volume":"82","author":"Lei","year":"2014","journal-title":"Infect Immun."},{"key":"B12","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/IAI.65.8.3361-3369.1997","article-title":"Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge","volume":"65","author":"Pal","year":"1997","journal-title":"Infect Immun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1073\/pnas.0508983103","article-title":"Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen","volume":"103","author":"Crane","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","first-page":"188","article-title":"Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine","volume":"40","author":"Ifere","year":"2007","journal-title":"J Microbiol Immunol Infect."},{"key":"B15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1128\/IAI.01280-06","article-title":"Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production","volume":"75","author":"Murthy","year":"2007","journal-title":"Infect Immun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1574-695X.2008.00493.x","article-title":"A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin","volume":"55","author":"Ekong","year":"2009","journal-title":"FEMS Immunol Med Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e10768","DOI":"10.1371\/journal.pone.0010768","article-title":"Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model","volume":"5","author":"Olsen","year":"2010","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1016\/j.vaccine.2017.04.017","article-title":"Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology","volume":"35","author":"Muller","year":"2017","journal-title":"Vaccine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.vaccine.2017.02.020","article-title":"The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge","volume":"35","author":"Pal","year":"2017","journal-title":"Vaccine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2017.00569","article-title":"Simultaneous subcutaneous and intranasal administration of a CAF01-adjuvanted Chlamydia vaccine elicits elevated IgA and protective Th1\/Th17 responses in the genital tract","volume":"8","author":"Wern","year":"2017","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1016\/j.vaccine.2017.05.063","article-title":"Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology","volume":"35","author":"O'Meara","year":"2017","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B23","first-page":"1477","article-title":"A chlamydial major outer membrane protein extract as a trachoma vaccine candidate","volume":"36","author":"Campos","year":"1995","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/imm.12520","article-title":"A vaccine formulated with the major outer membrane protein can protect C3H\/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge","volume":"146","author":"Pal","year":"2015","journal-title":"Immunology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1016\/j.vaccine.2011.02.057","article-title":"Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.vaccine.2005.08.097","article-title":"Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1016\/j.vaccine.2011.05.013","article-title":"Induction of protection against vaginal shedding and infertility by a recombinant Chlamydia vaccine","volume":"29","author":"Carmichael","year":"2011","journal-title":"Vaccine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1016\/j.vaccine.2011.06.105","article-title":"A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors","volume":"29","author":"Cheng","year":"2011","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1016\/j.vaccine.2011.04.065","article-title":"Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine","volume":"29","author":"Tifrea","year":"2011","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/0264-410X(95)00017-U","article-title":"Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection","volume":"13","author":"Su","year":"1995","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1128\/IAI.68.3.1719-1723.2000","article-title":"T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans","volume":"68","author":"Ortiz","year":"2000","journal-title":"Infect Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4236\/wjv.2011.14014","article-title":"A peptide containing t-cell epitopes of Chlamydia trachomatis recombinant MOMP induces systemic and mucosal antibody responses in mice","volume":"1","author":"Taha","year":"2011","journal-title":"World J Vaccines"},{"key":"B35","doi-asserted-by":"publisher","first-page":"325101","DOI":"10.1088\/0957-4484\/23\/32\/325101","article-title":"Biodegradable PLGA85\/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide","volume":"23","author":"Taha","year":"2012","journal-title":"Nanotechnology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.nano.2014.02.009","article-title":"Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice","volume":"10","author":"Dixit","year":"2014","journal-title":"Nanomedicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/sji.12150","article-title":"Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia","volume":"79","author":"Medhane","year":"2014","journal-title":"Scand J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/icb.2015.79","article-title":"A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-gamma(+) CMI responses protects against a genital infection in minipigs","volume":"94","author":"Boje","year":"2016","journal-title":"Immunol Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1016\/j.vaccine.2017.04.031","article-title":"Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biomaterials.2017.12.019","article-title":"Caveolin-mediated endocytosis of the Chlamydia M278 outer membrane peptide encapsulated in poly(lactic acid)-Poly(ethylene glycol) nanoparticles by mouse primary dendritic cells enhances specific immune effectors mediated by MHC class II and CD4(+) T cells","volume":"159","author":"Dixit","year":"2018","journal-title":"Biomaterials"},{"key":"B41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.micinf.2013.11.009","article-title":"A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge","volume":"16","author":"Cheng","year":"2014","journal-title":"Microbes Infect."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e61962","DOI":"10.1371\/journal.pone.0061962","article-title":"Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology","volume":"8","author":"O'Meara","year":"2013","journal-title":"PLoS ONE"},{"key":"B43","doi-asserted-by":"publisher","first-page":"aaa8205","DOI":"10.1126\/science.aaa8205","article-title":"VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells","volume":"348","author":"Stary","year":"2015","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/14760584.2018.1435279","article-title":"Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles","volume":"17","author":"Sahu","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"B45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1128\/CDLI.11.1.119-122.2004","article-title":"Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 Sao Paulo epidemic","volume":"11","author":"Pannuti","year":"2004","journal-title":"Clin Diagn Lab Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/168.2.415","article-title":"Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings","volume":"168","author":"Byrne","year":"1993","journal-title":"J Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v2i0.20181","article-title":"Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro","volume":"2","author":"Bartolini","year":"2013","journal-title":"J Extracell Vesicles"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.ppat.1001339","article-title":"Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts","volume":"7","author":"Asquith","year":"2011","journal-title":"PLoS Pathog."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.4049\/jimmunol.1303392","article-title":"Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum","volume":"192","author":"Tifrea","year":"2014","journal-title":"J. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect Immun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1016\/j.vaccine.2013.01.024","article-title":"Chlamydia trachomatis control requires a vaccine","volume":"31","author":"Brunham","year":"2013","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e00543","DOI":"10.1128\/CVI.00543-16","article-title":"Update on Chlamydia trachomatis Vaccinology","volume":"24","author":"de","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/vaccines4040034","article-title":"Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting","volume":"4","author":"Gutjahr","year":"2016","journal-title":"Vaccines"},{"key":"B57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jconrel.2017.12.003","article-title":"A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522","volume":"271","author":"Rose","year":"2018","journal-title":"J Control Release"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.023","article-title":"Status of vaccine research and development of vaccines for Chlamydia trachomatis infection","author":"Poston","year":"2017","journal-title":"Vaccine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2147\/IJN.S14912","article-title":"Recent advances in PEG-PLA block copolymer nanoparticles","volume":"5","author":"Xiao","year":"2010","journal-title":"Int J Nanomedicine"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3390\/ijms12021371","article-title":"Biodegradable tri-block copolymer poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)(PLA-PEG-PLL) as a non-viral vector to enhance gene transfection","volume":"12","author":"Fu","year":"2011","journal-title":"Int J Mol Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2004.04.026","article-title":"Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density","volume":"98","author":"Vila","year":"2004","journal-title":"J Control Release"},{"key":"B62","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s11671-009-9345-3","article-title":"Preparation and characterization of cationic PLA-PEG nanoparticles for delivery of plasmid DNA","volume":"4","author":"Zou","year":"2009","journal-title":"Nanoscale Res Lett."},{"key":"B63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ijpharm.2009.12.013","article-title":"PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B","volume":"387","author":"Jain","year":"2010","journal-title":"Int J Pharm."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1021\/acs.biomac.5b01150","article-title":"Design and development of immunomodulatory antigen delivery systems based on peptide\/PEG-PLA conjugate for tuning immunity","volume":"16","author":"Coumes","year":"2015","journal-title":"Biomacromolecules"},{"key":"B65","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1128\/IAI.73.12.8153-8160.2005","article-title":"Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria","volume":"73","author":"Pal","year":"2005","journal-title":"Infect. Immun."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1128\/IAI.70.3.1301-1309.2002","article-title":"Characterization of humoral and cellular immune responses elicited by meningococcal carriage","volume":"70","author":"Robinson","year":"2002","journal-title":"Infect Immun."},{"key":"B67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1084\/jem.20050137","article-title":"Differential contributions of central and effector memory T cells to recall responses","volume":"202","author":"Roberts","year":"2005","journal-title":"J Exp Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1615\/CritRevImmunol.2014010373","article-title":"CD4 T-cell memory generation and maintenance","volume":"34","author":"Gasper","year":"2014","journal-title":"Crit Rev Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.4049\/jimmunol.1002952","article-title":"Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells","volume":"186","author":"Yu","year":"2011","journal-title":"J Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1128\/IAI.00749-16","article-title":"IFNgamma is required for optimal antibody-mediated immunity against genital Chlamydia infection","volume":"84","author":"Naglak","year":"2016","journal-title":"Infect. Immun."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e2020","DOI":"10.1371\/journal.pntd.0002020","article-title":"Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis","volume":"7","author":"Hu","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"B72","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1128\/IAI.01378-15","article-title":"Tissue-Resident T Cells as the Central Paradigm of Chlamydia Immunity","volume":"84","author":"Johnson","year":"2016","journal-title":"Infect Immun."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e00010","DOI":"10.1128\/CVI.00010-17","article-title":"The predominant CD4(+) Th1 cytokine elicited to Chlamydia trachomatis infection in women is tumor necrosis factor alpha and not interferon gamma","volume":"24","author":"Jordan","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1016\/j.vaccine.2014.04.005","article-title":"Antibody avidity measurements in recipients of Cervarix vaccine following a two-dose schedule or a three-dose schedule","volume":"32","author":"Boxus","year":"2014","journal-title":"Vaccine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1128\/CVI.00154-07","article-title":"Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis\/Hib combination vaccines","volume":"14","author":"Denoel","year":"2007","journal-title":"Clin Vaccine Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1086\/515298","article-title":"Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines","volume":"177","author":"Anttila","year":"1998","journal-title":"J Infect Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.4161\/hv.24340","article-title":"Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial","volume":"9","author":"Safaeian","year":"2013","journal-title":"Hum Vaccin Immunother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/CVI.00521-12","article-title":"Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection","volume":"20","author":"Alam","year":"2013","journal-title":"Clin Vaccine Immunol."},{"key":"B80","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.39.3.1491-1494.1983","article-title":"Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix","volume":"39","author":"Brunham","year":"1983","journal-title":"Infect Immun."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: does size matter?","volume":"40","author":"Xiang","year":"2006","journal-title":"Methods"},{"key":"B82","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/excr.2001.5202","article-title":"Association of caveolin with Chlamydia trachomatis inclusions at early and late stages of infection","volume":"266","author":"Norkin","year":"2001","journal-title":"Exp Cell Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2334-4-23","article-title":"Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1","volume":"4","author":"Webley","year":"2004","journal-title":"BMC Infect Dis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1023\/A:1011922819926","article-title":"Stealth PLA-PEG nanoparticles as protein carriers for nasal administration","volume":"15","author":"Tobio","year":"1998","journal-title":"Pharm Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"PLA-PEG particles as nasal protein carriers: the influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int J Pharm."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T21:10:52Z","timestamp":1605215452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,15]]},"references-count":85,"alternative-id":["10.3389\/fimmu.2018.02369"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02369","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,15]]},"article-number":"2369"}}